When small institutions align with data-driven enrollment engines, they produce outcomes that speak for themselves.

Kyverna Therapeutics (KYTX) is rated a strong buy with promising KYV-101 Phase 2 data and near-term catalysts. Read here for ...

In the world of phylogenetics, there's team sponge and team comb jelly. Which creature roots the animal tree of life—the simple sponge or the more complex comb jelly—has stirred fierce debate among ...

Ionic defects are present in every frost sheet. Jonathan Boreyko’s team at Virginia Tech has used a high-voltage technique to ...

From cancer-resistant mole rats to 200-year-old whales, evolution has equipped long-lived species with unique biological ...

In the lingo of the field, dopamine-producing cells are measuring a reward prediction error — the difference between the ...

We all start somewhere. In the app world, that “somewhere” is usually zero downloads, zilch users, zip revenue. Whether you’re a bright-eyed start-up or a legacy brand elbowing your way into the ...

Much of mainstream economics holds to the Efficient Market Hypothesis (EMH), which is built on highly unrealistic foundations ...

Massachusetts researchers examine how growth and learning are subtly shaped among children whose mothers had Covid-19 while ...

Today in the Planet Money newsletter, five recent papers that lit lightbulbs in our brains, and are maybe worth taking a look ...

NEW YORK (AP) — Eliud Kipchoge and Sifan Hassan are at different ends of their marathon careers. Kipchoge, who turns 41 next week, is wrapping up a historic run as one of the most accomplished ...